Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Neo Soma Healthcare vs RxSaludable

Neo Soma Healthcare
Graded #213

Higher grade

vs+2.5999999999999943
RxSaludable
Graded #259

Lower grade

The verdict

Neo Soma Healthcare takes it — 65.8/100 to 63.2/100.

Neo Soma Healthcare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Neo Soma Healthcare is a multi-product DTC telehealth platform pairing compounded GLP-1 weight management with sexual-health and anti-aging lines.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNeo Soma Healthcare +15
66
51
Dose & formulationRxSaludable +5
72
77
Clinical oversightRxSaludable +10
72
82
Labs & monitoringNeo Soma Healthcare +9
62
53
FulfillmentRxSaludable +19
57
76
Contract termsNeo Soma Healthcare +35
55
20
Neo Soma Healthcare · left barRxSaludable · right bar

The numbers

MetricNeo Soma HealthcareRxSaludable
WeighScore65.8/10063.2/100
GradeCC
Scorecard rank#213#259
Semaglutide$199/mo$179/mo (compounded)
Tirzepatide$330/mo$269/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Neo Soma Healthcare

Graded #213 · C

Strengths

  • LegitScript verification badge present
  • Publishes the FDA compounded-medication disclaimer
  • Pricing shown publicly for all 6 product lines
  • Multi-product platform (GLP-1, sexual health, peptide therapies)
  • First-month discount on semaglutide ($99 entry)

Where it loses points

  • Pharmacy partner not named (503A vs 503B unclear)
  • States served not listed — no per-state availability table
  • No named medical director
  • Standard semaglutide pricing ($199/mo) above the cheapest providers ($150–180/mo)
  • Tirzepatide entry pricing ($330) above the cheapest providers (~$200–250/mo)
RxSaludable

Graded #259 · C

Strengths

  • Spanish-language platform with Spanish-speaking, U.S.-licensed providers — a genuine gap in GLP-1 telehealth
  • Compounded semaglutide $99 first month ($179/mo after) and tirzepatide $189 first month; same price at every dose, no membership fee
  • LegitScript-certified (#50274281); free expedited shipping; named obesity-medicine physicians
  • Same-day doctor visits, 24/7 support, FSA/HSA eligible, cancel anytime

Where it loses points

  • Ongoing prices ($179-289/mo) are mid-range once the first-month intro ends
  • Doesn't name its compounding pharmacy partners (generic 'certified pharmacies')
  • No legal entity name or explicit state-coverage list published on the site
  • Compounded GLP-1s are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard